Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...

The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness from ...

The 2025 "American Idol" champion stops by "GMA" to perform his new single, “Heal,” and reflect on his path to victory. A new Trump administration vaccine policy will limit access to COVID-19 shots.

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...